IPSC vs. MTA
IPSC (Century Therapeutics, Inc.) and MTA (Metalla Royalty & Streaming Ltd.) are both stocks. IPSC operates in Biotechnology (Healthcare), while MTA operates in Other Precious Metals & Mining (Basic Materials). Over the past 5 years, IPSC returned -41.37%/yr vs -2.11%/yr for MTA. Their 0.19 correlation means their historical movements had little consistent relationship.
Performance
IPSC vs. MTA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IPSC achieves a 103.06% return, which is significantly higher than MTA's -5.40% return.
IPSC
- 1D
- -7.76%
- 1M
- -16.87%
- 6M
- 6.32%
- YTD
- 103.06%
- 1Y
- 279.77%
- 3Y*
- -12.55%
- 5Y*
- -41.37%
- 10Y*
- —
- ALL TIME*
- -35.80%
MTA
- 1D
- -3.41%
- 1M
- -3.66%
- 6M
- -2.00%
- YTD
- -5.40%
- 1Y
- 86.33%
- 3Y*
- 17.22%
- 5Y*
- -2.11%
- 10Y*
- —
- ALL TIME*
- 16.88%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.42M | $2.12M | $2.88M | |
| $2.37M | $2.82M | $3.42M |
IPSC vs. MTA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
IPSC Century Therapeutics, Inc. | 103.06% | -1.50% | -69.58% | -35.28% | -67.65% | -18.67% |
MTA Metalla Royalty & Streaming Ltd. | -5.40% | 209.96% | -18.51% | -36.95% | -29.15% | -31.72% |
Correlation
The correlation between IPSC and MTA is 0.24, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.24 |
Correlation (3Y) Balances recent behavior with more history. | 0.21 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jun 18, 2021 | 0.19 |
Fundamentals
IPSC:
$174.87M
MTA:
$687.74M
IPSC:
-$0.88
MTA:
-$0.04
IPSC:
1.48
MTA:
2.77
IPSC:
$0.00
MTA:
$14.70M
IPSC:
-$9.88M
MTA:
$12.51M
IPSC:
-$103.02M
MTA:
$3.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IPSC vs. MTA — Risk / Return Rank
IPSC
MTA
IPSC vs. MTA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Century Therapeutics, Inc. (IPSC) and Metalla Royalty & Streaming Ltd. (MTA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IPSC | MTA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.18 | ||
| Sortino ratioReturn per unit of downside risk | +1.41 | ||
| Omega ratioGain probability vs. loss probability | 1.42 | 1.26 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | 7.32 | 2.61 | +4.71 |
| Martin ratioReturn relative to average drawdown | 14.90 | 5.98 | +8.92 |
Loading charts...
Drawdowns
IPSC vs. MTA - Drawdown Comparison
The maximum IPSC drawdown since its inception was -98.78%, which is greater than MTA's maximum drawdown of -81.73%. Use the drawdown chart below to compare losses from any high point for IPSC and MTA.
Loading charts...
Drawdown Indicators
| IPSC | MTA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.78% | -81.73% | -17.05% |
Max Drawdown (1Y)Largest decline over 1 year | -36.98% | -33.04% | -3.94% |
Max Drawdown (3Y)Largest decline over 3 years | -92.68% | -45.56% | -47.12% |
Max Drawdown (5Y)Largest decline over 5 years | -98.78% | -71.47% | -27.31% |
Current DrawdownCurrent decline from peak | -93.67% | -43.75% | -49.92% |
Average DrawdownAverage peak-to-trough decline | -80.81% | -41.42% | -39.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.14% | 14.41% | +3.73% |
Volatility
IPSC vs. MTA - Volatility Comparison
Century Therapeutics, Inc. (IPSC) has a higher volatility of 16.98% compared to Metalla Royalty & Streaming Ltd. (MTA) at 15.09%. This indicates that IPSC's price experiences larger fluctuations and is considered to be riskier than MTA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IPSC | MTA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.98% | 15.09% | +1.89% |
Volatility (6M)Calculated over the trailing 6-month period | 51.48% | 42.27% | +9.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 97.17% | 53.69% | +43.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.40% | 53.76% | +29.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.64% | 57.11% | +26.53% |
Dividends
IPSC vs. MTA - Dividend Comparison
Neither IPSC nor MTA has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
IPSC Century Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MTA Metalla Royalty & Streaming Ltd. | 0.00% | 0.00% | 0.00% | 0.75% | 0.00% | 0.00% | 0.10% | 0.75% | 2.16% |
Financials
IPSC vs. MTA - Financials Comparison
This section allows you to compare key financial metrics between Century Therapeutics, Inc. and Metalla Royalty & Streaming Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IPSC and MTA have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IPSC has higher volatility (16.98%) compared to MTA (15.09%). In terms of maximum drawdown, IPSC dropped -98.78% vs MTA's -81.73%.
IPSC currently has the higher Sharpe Ratio (2.79 vs 1.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IPSC and MTA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer